Key facts
as of Sep 2026- Capri Medical’s last known valuation is $24.6M (Dec 2024).
- It has raised $10.8M; the latest was Later Stage VC ($8.3M) in Dec 2024.
- Notable investors include Enterprise Ireland, European Innovation Council, Horizon Europe.
- 5 institutional filers report fund marks on Capri Medical across 39 filings.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Capri Medical
- ·The full record, as it builds
Recorded secondary trades
No secondary trades in Capri Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
5 filers · latest Jun 20265 SEC-registered funds reported 39 fair-value marks on Capri Medical between Apr 2025 and Jun 2026. Filer-level marks and implied $/share are available to Pro members.
Funding rounds
No funding rounds for Capri Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Capri Medical
Developer of implantable neurostimulation devices designed for the treatment of chronic peripheral nerve pain. The company's device stimulates the peripheral nervous system to address the world's pressing healthcare needs, enabling medical providers to offer patient comfort while delivering advanced technical performance.
- Sector
- Healthcare
- HQ
- Dublin, Ireland
- Founded
- 2018
- Employees
- 7
- Website
- capri-medical.com/
- Ownership
- Privately Held (backing)